Registration for PeproTech.com is no longer available. To order your PeproTech products online, register or logon to ThermoFisher.com.

Chemokines

Recombinant Human MDC (CCL22) (67 a.a.)

0 리뷰Submit a Review

제품 상세

카다로그 번호 300-36
제품 설명
Recombinant Human MDC (CCL22) (67 a.a.)

MDC is a CC chemokine that is produced in B cells, macrophages, monocyte-derived dendritic cells, activated NK cells, and CD4 T cells. It signals through the CCR4 receptor. MDC chemoattracts monocytes, dendritic cells and NK cells, and exerts HIV-suppressive activity. The 67 amino acid form of MDC displays reduced chemoattractant activity, but retains HIV-suppressive activity. Recombinant Human MDC is an 8.0 kDa protein containing 67 amino acid residues including the four highly conserved cysteine residues present in the CC chemokines.

Source: E.coli

Synonyms: Macrophage-Derived Chemokine, CCL22, STCP-1, ABCD-1

AA Sequence: YGANMEDSVC CRDYVRYRLP LRVVKHFYWT SDSCPRPGVV LLTFRDKEIC ADPRVPWVKM ILNKLSQ

Purity: ≥ 98% by SDS-PAGE gel and HPLC analyses.

Biological Activity: Determined by its ability to chemoattract human T cells using a concentration range of 10.0-100.0 ng/ml.

Calculated Molecular Weight: 8 kDa

Accession Number: O00626

Gene ID: 6367

Endotoxin: Endotoxin level is < 0.1 ng/ug of protein (< 1 EU/ug)

crossreactivity:
Country Of Origin: USA

Not for human use.

Research Interest

product.subtitle.recentcitations

제 1 저자
Anderson, C A
주제
A degradatory fate for CCR4 suggests a primary role in Th2 inflammation.
인용
Journal of Leukocyte Biology; 107(3) pg455-466
PubMed ID
제 1 저자
Pickering, R J
주제
Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis.
인용
The Journal of Clinical Investigation; 129(1) pg406-421
PubMed ID
제 1 저자
Zhang, Y
주제
A new antagonist for CCR4 attenuates allergic lung inflammation in a mouse model of asthma.
인용
Scientific Reports; 7(1) pg15038
PubMed ID